Clinical Trial Update: Erlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or Adenoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating erlotinib hydrochloride in patients with stage I-III colorectal cancer or adenomatous polyps; the study is completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenomatous Polyp
• Colon Cancer
• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• ERLOTINIB (Erlotinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adenomatous Polyp, Recurrent Colon Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-01-06